Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Return to: PBR Home | Production & Manufacturing
Today in Production & Manufacturing

Production & Manufacturing

Novartis acquires Selexys Pharmaceuticals in $665m deal Novartis has acquired Selexys Pharmaceuticals, an Oklahoma City based company specializing in hematologic and inflammatory disorders, in a deal worth about $665m. Production & Manufacturing > Manufacturing > News

Latest Production & Manufacturing News by Sector

Select a sector from the list or browse by sector below:

Fine & Speciality Chemicals

Bayer plans to focus entirely on Life Science businesses
Bayer intends in the future to focus entirely on the Life Science businesses – HealthCare and CropScience – and float MaterialScience on the stock market as a separate company. In this way Bayer is positioning itself as a world-leading company in the field of human, animal and plant health.
Production & Manufacturing > Fine & Speciality Chemicals > News
CordenPharma agrees to purchase Peptisyntha from Solvay
By PBR Staff Writer
International Chemical Investors Group (ICIG) and the Solvay Group have embarked on an agreement, whereby ICIG will purchase Belgium-based Peptisyntha SA, a custom manufacturer of peptides for pharmaceutical use.
Production & Manufacturing > Fine & Speciality Chemicals > News

Process & Production

Cascadian Therapeutics amends HER2CLIMB phase 2 trial of tucatinib
Cascadian Therapeutics announced that after a recent meeting with the US Food and Drug Administration (FDA) and discussions with the Company's external Steering Committee, it has amended the HER2CLIMB Phase 2 clinical trial of tucatinib (also known as ONT-380) by increasing the sample size so that, if successful, the trial could serve as a single pivotal study to support registration.
Production & Manufacturing > Process & Production > News
FDA grants fast track designation for Theravance's Velusetrag for idiopathic and diabetic gastroparesis
Theravance Biopharma has secured fast track designation from the US Food and Drug Administration (FDA) to velusetrag (TD-5108) for the treatment of symptoms associated with idiopathic and diabetic gastroparesis.
Production & Manufacturing > Process & Production > News

OTC

Catalent to acquire OTC softgel maker Accucaps Industries
By PBR Staff Writer
US based Catalent has agreed to acquire Accucaps Industries, a Canadian pharmaceutical contract development and manufacturing organization specializing in the soft gelatin dose form.
Production & Manufacturing > OTC > News
US FTC issues enforcement policy statement on marketing claims for OTC homeopathic drugs
The US Federal Trade Commission (FTC) has issued a new enforcement policy statement regarding marketing claims for over-the-counter (OTC) homeopathic drugs.
Production & Manufacturing > OTC > News

Manufacturing

UK's CMA fines Pfizer and Flynn Pharma for epilepsy drug price hike
By PBR Staff Writer
Pfizer and Flynn Pharma have been fined a record amount for abusing their dominant position in the UK by charging excessive and unfair prices for an anti-epilepsy drug.
Production & Manufacturing > Manufacturing > News
Heptares to buy G7 Therapeutics to expand GPCR capabilities
By PBR Staff Writer
Sosei Group's subsidiary Heptares Therapeutics has agreed to acquire Swiss drugmaker G7 Therapeutics for CHF12m ($11.8m).
Production & Manufacturing > Manufacturing > News